152 related articles for article (PubMed ID: 25765358)
1. Early serum human chorionic gonadotropin (hCG) trends after medication abortion.
Pocius KD; Maurer R; Fortin J; Goldberg AB; Bartz D
Contraception; 2015 Jun; 91(6):503-6. PubMed ID: 25765358
[TBL] [Abstract][Full Text] [Related]
2. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB
Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046
[TBL] [Abstract][Full Text] [Related]
3. Monitoring medical abortion using mifepristone/misoprostol combination with ultrasonogram and serum human chorionic gonadotropin.
Chou SY; Chen CY; Chiang HK; Chow PK; Wang CC; Hsu CS
Taiwan J Obstet Gynecol; 2006 Mar; 45(1):48-52. PubMed ID: 17272208
[TBL] [Abstract][Full Text] [Related]
4. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol.
Creinin MD
Am J Obstet Gynecol; 1996 Feb; 174(2):776-8. PubMed ID: 8623820
[TBL] [Abstract][Full Text] [Related]
5. Trend of serum beta-human chorionic gonadotropin levels after medical abortion in the early first trimester of pregnancy.
Choobun T; Maneeon R
J Obstet Gynaecol Res; 2023 Jan; 49(1):103-108. PubMed ID: 36184565
[TBL] [Abstract][Full Text] [Related]
6. hCG trends after mifepristone and misoprostol for undesired pregnancy of unknown location.
Bharadwa S; Fulcher I; Fortin J; Pocius KD; Goldberg AB
Contraception; 2024 Mar; 131():110343. PubMed ID: 38008304
[TBL] [Abstract][Full Text] [Related]
7. Serum hCG threshold to assess medical abortion success.
Le Lous M; Gallinand AC; Laviolle B; Peltier L; Nyangoh Timoh K; Lavoué V
Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):458-463. PubMed ID: 30601107
[TBL] [Abstract][Full Text] [Related]
8. Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
Goldberg AB; Fulcher IR; Fortin J; Hofer RK; Cottrill A; Dethier D; Gilbert A; Janiak E; Roncari D
Obstet Gynecol; 2022 May; 139(5):771-780. PubMed ID: 35576336
[TBL] [Abstract][Full Text] [Related]
9. Ovulation resumption after medical abortion with mifepristone and misoprostol.
Schreiber CA; Sober S; Ratcliffe S; Creinin MD
Contraception; 2011 Sep; 84(3):230-3. PubMed ID: 21843685
[TBL] [Abstract][Full Text] [Related]
10. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy.
Honkanen H; Ranta S; Ylikorkala O; Heikinheimo O
Hum Reprod; 2002 Sep; 17(9):2315-9. PubMed ID: 12202418
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
Blum J; Sheldon WR; Ngoc NT; Winikoff B; Nga NT; Martin R; Van Thanh L; Blumenthal PD
Contraception; 2016 Aug; 94(2):115-21. PubMed ID: 27067706
[TBL] [Abstract][Full Text] [Related]
12. Medical abortion with mifepristone and misoprostol: a clinical trial in Taiwanese women.
Tsai EM; Yang CH; Lee JN
J Formos Med Assoc; 2002 Apr; 101(4):277-82. PubMed ID: 12101864
[TBL] [Abstract][Full Text] [Related]
13. Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness.
Parashar P; Iversen OE; Midbøe G; Myking O; Bjørge L
Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):366-71. PubMed ID: 17853164
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of terminating biochemical pregnancy and early clinical pregnancy with mifepristone and misoprostol].
Li CL; Wei M; Fu MF; Li M
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):542-5. PubMed ID: 17983494
[TBL] [Abstract][Full Text] [Related]
15. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
[TBL] [Abstract][Full Text] [Related]
16. An overview of medical abortion for clinical practice.
Bryant AG; Regan E; Stuart G
Obstet Gynecol Surv; 2014 Jan; 69(1):39-45. PubMed ID: 25102250
[TBL] [Abstract][Full Text] [Related]
17. Serum human chorionic gonadotropin decline following aspiration abortion in early pregnancy less than 42 days gestation.
Baldwin MK; Bednarek PH; Russo J
Contraception; 2021 Feb; 103(2):113-115. PubMed ID: 33227249
[TBL] [Abstract][Full Text] [Related]
18. Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
Roe AH; Abernathy A; Flynn AN; McAllister A; Koelper NC; Sammel MD; Schreiber CA; Sonalkar S
Obstet Gynecol; 2022 Jun; 139(6):1149-1151. PubMed ID: 35675613
[TBL] [Abstract][Full Text] [Related]
19. Combined methotrexate and misoprostol for early induced abortion.
Schaff EA; Eisinger SH; Franks P; Kim SS
Arch Fam Med; 1995 Sep; 4(9):774-9. PubMed ID: 7647943
[TBL] [Abstract][Full Text] [Related]
20. Early pregnancy termination with mifepristone and misoprostol in the United States.
Spitz IM; Bardin CW; Benton L; Robbins A
N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
